HIV molecular immunology database

 

Search the Epitope Variant and Escape Mutation Database

Results for CTL/CD8+ T-Cell Epitope Variants

Filter results by Mutation Type:

LKETINEEAAEWDRV Gag(201-215) A25 human epitope
LKETINEEAAEWDRL Gag(201-215) H-2d transgenic mouse epitope
LKDTINEEAAEWDRLHPV Gag(201-218) A*68:01 human epitope
LKETINEEAAEWDRLHPV Gag(201-218) human epitope
LKdTINEEAAEWDRLHPV Gag(201-218) subtype-specific susceptible form
LKETINEEAAEWDRVPV Gag(201-218) human epitope
LKETINEEAAEWDRLHPV Gag(201-218) human epitope
 KDTINEEAAEWDRL Gag(202-215) human epitope
  DTINEEAAEWDRIYK Gag(203-217) human epitope
  ETINEEAAEWDRVHPVVHAGP Gag(203-222) human epitope
   TINEEAAEWDRLHPV Gag(204-218) human epitope
   TINEEAAEWDRLHPV Gag(204-218) human epitope
   TINEEAAEWDRLHPVHAG Gag(204-221) human epitope
    INEEAAEWDRVHPVH Gag(205-219) A2 human epitope
    INEEAAEWDRLHPVH Gag(205-219) human epitope
    INEEAAEWDRVHPVH Gag(205-219) human epitope
    INEEAAEWDRlHPVH Gag(205-219) susceptible form
    INEEAAEWDRLHPVH Gag(205-219) human epitope
    INEEAAEWDRLHPVH Gag(205-219) human epitope
    INEEAAEWDRvHPVH Gag(205-219) susceptible form
      EEAAEWDRV Gag(207-215) B*40 human epitope
      EEAAEWDRl Gag(207-215) subtype-specific susceptible form
      EEAAEWDRL Gag(207-215) B40 human epitope
      EEAAEWDRL Gag(207-215) human epitope
      EEAAEWDRIYKRWII Gag(207-218) human epitope
       EAAEWDRLH Gag(208-216) human epitope
       EAAEWDRLHPVHAGP Gag(208-222) human epitope
        AAEWDRLHP Gag(209-217) human epitope
        AAEWDRLHPV Gag(209-218) human epitope
        AAEWDRmHPV Gag(209-218) HLA association; diminished HLA binding or increased off-rate
        AAEWDRaHPV Gag(209-218) HLA association
        AAEWDRqHPV Gag(209-218) HLA association; diminished HLA binding or increased off-rate
        AAEWDRsHPV Gag(209-218) HLA association
        AAEWDRtHPV Gag(209-218) HLA association
        AAEWDRvHPV Gag(209-218) HLA association
        AAEWDRiHPV Gag(209-218) HLA association
        -AEWDRxHPV Gag(209-218) HLA association; diminished HLA binding or increased off-rate
        AAEWDRxHP- Gag(209-218) HLA association; diminished HLA binding or increased off-rate
        AAEWDRLHPVH Gag(209-219) human epitope
        AAEWDRVHPVHAGPI Gag(209-223) A2, B40, B44 human epitope
        AAEWDRLHPVHAGPI Gag(209-223) H-2d mouse epitope
        AAEWDRLHPVHAGPI Gag(209-223) human epitope
        AAEWDRvHPVHAGPI Gag(209-223) susceptible form
        AAEWDRLHPVHAGPI Gag(209-223) human epitope
        AAEWDRLHPVHAGPI Gag(209-223) mouse epitope
        AAEWDRVHPVHAGPI Gag(209-223) human epitope
        AAEWDRlHPVHAGPI Gag(209-223) susceptible form
        AAEWDRLHPVHAGPI Gag(209-223) human epitope
        AAEWDRLHPVHAGPIA Gag(209-224) human epitope
        AAEWDRLHPVHAGPIA Gag(209-224) human epitope
        AAEWDRLHPVHAGPIA Gag(209-224) human epitope
         AEWDRLHP Gag(210-217) B*40:02 human epitope
         AEWDRvHP Gag(210-217) subtype-specific susceptible form
         AEWDRVHP Gag(210-217) B*40:02 human epitope
         AEWDRlHP Gag(210-217) subtype-specific susceptible form
         AEWDRLHPV Gag(210-218) A2 human epitope
         AEWDRLHPV Gag(210-218) A2 human epitope
         AEWgRLHPV Gag(210-218) observed variant
         AdWDRvHPV Gag(210-218) observed variant
         AE*DRLHPV Gag(210-218) observed variant
         AEWDRLHPV Gag(210-218) A2 human epitope
         AEWDRVHPV Gag(210-218) A*23 human epitope
         AEWDRVHPV Gag(210-218) B*18 human epitope
         AEWDRVHPV Gag(210-218) B*35:02, B*35:03, B*53:01 human epitope
         AEWDRVHPV Gag(210-218) B*40 human epitope
         AEWDRlHPV Gag(210-218) subtype-specific susceptible form
         AEWDRLHPV Gag(210-218) B*40 human epitope
         AEWDRVHPV Gag(210-218) B*40 human epitope
         AEWDRLHPV Gag(210-218) B40 human epitope
         AEWDRVHPV Gag(210-218) B40 human epitope
         AEWDRLHPV Gag(210-218) B*40:02 human epitope
         AEWDRVHPV Gag(210-218) B*40:02 human epitope
         AEWDRVHPV Gag(210-218) B*40:02 human epitope
         AEWDRVHPV Gag(210-218) B*40:02 human epitope
         AEWDRlHPV Gag(210-218) subtype-specific susceptible form
         AEWDRLHPV Gag(210-218) B*40:02 human epitope
         AEWDRvHPV Gag(210-218) subtype-specific susceptible form
         AEWDRLHPV Gag(210-218) B*40:06 human epitope
         AEWDRVHPV Gag(210-218) human epitope
         {A}tEWDRVHPV{HAGPIPPG} Gag(210-218) observed variant
         {A}AdWDRVHPV{HAGPIPPG} Gag(210-218) observed variant
         {A}AdWDRgHPV{HAGPIPPG} Gag(210-218) observed variant
         {A}AdWDRgHPV{HAGPIPlG} Gag(210-218) observed variant
         {A}vEWDRaHPi{HAGPIPPG} Gag(210-218) observed variant
         AEWDRVHPV Gag(210-218) human epitope
          EWDRVHPV Gag(211-218) A2 human epitope
          EWDRLHPVHAG Gag(211-221) B*40:02 human epitope
          EWDRvHPVHAG Gag(211-221) subtype-specific susceptible form
          EWDRVHPVHAG Gag(211-221) B*40:02 human epitope
          EWDRlHPVHAG Gag(211-221) subtype-specific susceptible form
          EWDRLHPVHAGPIAPGQMRE Gag(211-230) human epitope
           WDRLHPVHAGPIAPGQMR Gag(212-229) human epitope
            DRVHPVHAGPI Gag(213-223) macaque epitope
            DRVHPVHAGPIAPGQ Gag(213-227) B7 human epitope
            DRLHPVHAGPIAPGQ Gag(213-227) human epitope
            DRvHPVHAGPIAPGQ Gag(213-227) susceptible form
            DRLHPVHAGPIAPGQ Gag(213-227) human epitope
            DRLHPVHAGPAAPGQMREPR Gag(213-232) human epitope
            DRLHPVHAGPiAPGQMREPR Gag(213-232) diminished response
             RLHPVHAGP Gag(214-222) human epitope
             RLHPVHAGPIA Gag(214-224) A*02 human epitope
             RLHPVHAGPIA Gag(214-224) human epitope
              LHPVHAGPI Gag(215-223) human epitope
              VHPVHAGPIA Gag(215-224) B55 human epitope
              VHPVHAGPIA Gag(215-224) B55 human epitope
              lHPVHAGPvA Gag(215-224) susceptible form
              lHPVHAGPIA Gag(215-224) susceptible form
              lHPVHAGPIt Gag(215-224) susceptible form
              lHPaqAGPIA Gag(215-224) susceptible form
               HPVHAGPI Gag(216-223) B35 human epitope
               HPVHAGPI Gag(216-223) B35 human epitope
               HPVHAGPV Gag(216-223) B35 human epitope
               HPVHAGPV Gag(216-223) human epitope
               HPVHAGPi Gag(216-223) susceptible form
               HPVHAGPI Gag(216-223) human epitope
               HPVHAGPv Gag(216-223) susceptible form
               HPVHAGPIA Gag(216-224) A*68:02 human epitope
               HPVHAGPIA Gag(216-224) B*07 human epitope
               HPVHAGPvA Gag(216-224) observed variant
               HPVHAGPIA Gag(216-224) B*07 human epitope
               HPVHAGPIA Gag(216-224) B*07:02 human epitope
               HPVHAGPIA Gag(216-224) B*07:02 human epitope
               HPVHAGPIA Gag(216-224) B35 human epitope
               HPVHAGPIA Gag(216-224) B35 human epitope
               HPVHAGPIA Gag(216-224) B35, B7 human epitope
               HPVHAGPIA Gag(216-224) B*35:01 human epitope
               HPVHAGPIA Gag(216-224) B*35:01 human epitope
               HPVHAGPIA Gag(216-224) B*35:01 human epitope
               HPVHAGPIA Gag(216-224) B*35:01 human epitope
               HPVHAGPIA Gag(216-224) B*35:01 human epitope
               HPVHAGPIA Gag(216-224) B*35:02, B*35:03, B*53:01 human epitope
               HPVHAGPIA Gag(216-224) B39, B7 human epitope
               HPVHAGPIA Gag(216-224) B*39:10 human epitope
               HPVHAGPIA Gag(216-224) B*55 human epitope
               HPVHAGPVA Gag(216-224) B7 human epitope
               HPVHAGPIA Gag(216-224) B7 human epitope
               HPVHAGPIA Gag(216-224) B7 human epitope
               HPVHAGPVA Gag(216-224) B7 human epitope
               HPVHAGPIA Gag(216-224) B7 human epitope
               HPVHAGPIA Gag(216-224) B7 human epitope
               HPVHAGPIA Gag(216-224) B7 human epitope
               HPVHAGPIA Gag(216-224) B7 human epitope
               HPVHAGPVA Gag(216-224) B7 human epitope
               HPVHAGPVA Gag(216-224) B7 human epitope
               HPVHAGPIA Gag(216-224) B7 human epitope
               HPVHAGPVA Gag(216-224) B7 supertype human epitope
               HPVqAGPVA Gag(216-224) non-susceptible form; susceptible form
               HPVHAGPiA Gag(216-224) non-susceptible form; susceptible form
               HPVHAGPip Gag(216-224) non-susceptible form; susceptible form
               HPVHAGPVp Gag(216-224) non-susceptible form; susceptible form
               HPaHAGPVA Gag(216-224) non-susceptible form; susceptible form
               HPVaAGPVA Gag(216-224) non-susceptible form; susceptible form
               HPVHvGPVA Gag(216-224) non-susceptible form; susceptible form
               HPVHAaPVA Gag(216-224) non-susceptible form; susceptible form
               HVPHAGPIA Gag(216-224) B7 supertype human, mouse epitope
               HPVHAGPIA Gag(216-224) C*12 human epitope
               HPVHAGPIA Gag(216-224) human epitope
               HPVHAGPVA Gag(216-224) human epitope
               HPVHAGPIA Gag(216-224) human epitope
               HPVHAGPIA Gag(216-224) human epitope
               HPVHAGPIAPGQMREPR Gag(216-232) A*02 human epitope
                 VHAGPIPPG Gag(218-226) human epitope
                  HAGPIAPGQMREPRG Gag(219-233) A*02 human epitope
                  HAGPIAPGQMREPRG Gag(219-233) A2 human epitope
                  qAGPIAPGQMRdPRG Gag(219-233) observed variant
                  HAGPIAPGQMREPRG Gag(219-233) A2 human epitope
                  HAGPIAPGQMREPRG Gag(219-233) human epitope
                    GPIAPGQM Gag(221-228) B35 human epitope
                    GPIAPGQM Gag(221-228) human epitope
                    GPIPPGQMR Gag(221-229) B*07:02 human epitope
                    GPIAPGQMREPRGSD Gag(221-235) H-2d transgenic mouse epitope
                      IGPGRARYAR Gag(223-232) mouse epitope
                      IAPGQMREPRGSDIA Gag(223-237) B*13 human epitope
                      IAPGQMREPRGSDIA Gag(223-237) human epitope
                      IAPGQMREPRGSDIA Gag(223-237) human epitope
                      IAPGQMREPRGSDIAGTTST Gag(223-242) human epitope
Questions or comments? Contact us at immuno@lanl.gov
 
Managed by Triad National Security, LLC for the U.S. Department of Energy’s National Nuclear Security Administration
Copyright © 2022 Triad National Security, LLC | Disclaimer/Privacy

Dept of Health & Human Services Los Alamos National Institutes of Health